NurExone Biologic Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	63	44	14	17	-
Market Cap Growth	42.22%	208.80%	-14.84%	-	-
Enterprise Value	62	41	13	12	-
Last Close Price	0.70	0.62	0.29	0.39	-
PB Ratio	31.28	17.35	57.03	5.89	-
P/TBV Ratio	31.28	17.35	57.03	5.89	-
Debt / Equity Ratio	0.05	0.02	6.44	0.01	0.89
Quick Ratio	1.28	2.08	0.34	4.17	1.67
Current Ratio	1.33	4.11	1.04	4.46	1.74
Return on Equity (ROE)	-298.06%	-517.23%	-318.51%	-499.17%	-
Return on Assets (ROA)	-129.23%	-135.79%	-92.09%	-123.02%	-
Return on Capital (ROIC)	-179.98%	-195.66%	-129.79%	-159.74%	-
Return on Capital Employed (ROCE)	-362.80%	-245.20%	-1395.80%	-252.90%	-142.20%
Earnings Yield	-14.34%	-16.51%	-33.76%	-66.15%	-
FCF Yield	-11.33%	-18.13%	-28.40%	-31.58%	-
Buyback Yield / Dilution	-27.20%	-46.27%	-18.52%	-129.35%	-

Source: S&P Capital IQ. Standard template. Financial Sources.